India, July 22 -- Oscar Health, Inc. (OSCR), Tuesday announced preliminary financial results for the second quarter, expecting a loss from operations of approximately $230 million and a net loss of about $228 million.
Moreover, the company has revised its full year 2025 outlook. It now anticipates total revenue of $12.0 billion to $12.2 billion, and an adjusted EBITDA loss of approximately $120 million less than the loss from operations.
Analysts, on average, estimate revenue of $11.24 billion for the same year.
In the pre-market hours, Oscar's stock is trading at $13.84, up 1.73 percent on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from...